White Paper

Strategies for Accelerating the Development of Modified Release Oral Forms

Pre-formulation screening

How do I access characterization techniques to speed the development of my molecule?
Quotient is your answer.

Quotient Sciences’ experienced material scientists can support your pre-formulation screening to allow selection of your drug candidate for preclinical evaluation and identification of your drug product in early clinical evaluation.

Our rapid screening approach uses techniques such as particle size analysis, solubility screening, amorphous content and candidate stability to identify your lead candidates, which can then be developed into formulations for preclinical evaluation as either simple solutions/suspensions or more complex formulations.

By rapidly screening excipients and selecting appropriate formulations, you can begin preclinical studies in a matter of weeks rather than months.

Pre-formulation screening

Go further with Quotient Sciences

Ask us a question

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.